The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Lynch, Aidan
    Chief Executive Officer born in April 1964
    Individual (1 offspring)
    Officer
    2018-10-29 ~ now
    OF - Director → CIF 0
    Mr Aidan Lynch
    Born in April 1964
    Individual (1 offspring)
    Person with significant control
    2018-10-29 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Right to appoint or remove directorsCIF 0
  • 2
    Lynch, Ros
    Director born in January 1995
    Individual (1 offspring)
    Officer
    2019-04-02 ~ now
    OF - Director → CIF 0
Ceased 3
  • 1
    Poynton, Ashley
    Spinal Trauma Consultant born in June 1969
    Individual
    Officer
    2019-10-29 ~ 2022-03-15
    OF - Director → CIF 0
  • 2
    Kwok, Chi Fung Jessica
    Researcher born in October 1976
    Individual
    Officer
    2019-11-25 ~ 2021-08-12
    OF - Director → CIF 0
  • 3
    Gildersleeve, John
    Director born in January 1965
    Individual (2 offsprings)
    Officer
    2019-11-27 ~ 2020-01-16
    OF - Director → CIF 0
parent relation
Company in focus

NEUROSOLV THERAPEUTICS LIMITED

Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Intangible Assets
66,031,975 GBP2023-10-31
66,031,975 GBP2022-10-31
Fixed Assets
66,031,975 GBP2023-10-31
66,031,975 GBP2022-10-31
Cash at bank and in hand
98,357 GBP2023-10-31
204,454 GBP2022-10-31
Current Assets
98,357 GBP2023-10-31
204,454 GBP2022-10-31
Net Current Assets/Liabilities
98,357 GBP2023-10-31
204,454 GBP2022-10-31
Total Assets Less Current Liabilities
66,130,332 GBP2023-10-31
66,236,429 GBP2022-10-31
Net Assets/Liabilities
66,130,332 GBP2023-10-31
66,236,429 GBP2022-10-31
Equity
Called up share capital
24 GBP2023-10-31
24 GBP2022-10-31
Retained earnings (accumulated losses)
-96,000 GBP2023-10-31
-122,000 GBP2022-10-31
Equity
66,130,332 GBP2023-10-31
66,236,429 GBP2022-10-31
Average Number of Employees
22022-11-01 ~ 2023-10-31
22021-11-01 ~ 2022-10-31
Intangible Assets - Gross Cost
66,031,975 GBP2023-10-31
66,031,975 GBP2022-10-31
Intangible Assets - Accumulated Amortisation & Impairment
0 GBP2023-10-31
0 GBP2022-10-31

  • NEUROSOLV THERAPEUTICS LIMITED
    Info
    Registered number NI656688
    Forsyth House, Cromac Square, Belfast BT2 8LA
    Private Limited Company incorporated on 2018-10-29 (6 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2025-04-08
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.